The need to measure quality of life in a prostate cancer screening trial.
Iverson
D
D
Office of Behavioral Research and Program Evaluation, National Cancer Institute of Canada, Toronto, Ontario.
D001294:Attitude to Health; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008403:Mass Screening; D011471:Prostatic Neoplasms / Q000517:prevention & control* / Q000523:psychology / Q000628:therapy; D011788:Quality of Life; D015203:Reproducibility of Results; D016896:Treatment Outcome